Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
Go back to Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update| (NASDAQ: ALLO) | Delayed: 2.08 -0.03 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.11 | 52 Week High | $ | |||
| Open | $2.13 | 52 Week Low | $ | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $ | |||
| Volume | 9,136,320 | |||||

